NEW YORK (GenomeWeb News) – CompanionDx Reference Lab and Enable Healthcare have partnered to provide physicians in Enable's network access to CompanionDx's pharmacogenomics testing.
Enable's physicians will use CompanionDx's services to make better informed decisions about patient therapies and medications and to identify poor and ultra-rapid metabolizers of drugs, CompanionDx said.
Enable is a health information technology services provider based in East Hanover, NJ. Houston-based CompanionDx is a high-complexity CLIA-certified lab specializing in pharmacogenomics, cancer companion diagnostics, targeted next-generation sequencing, and epigenomics testing.
Financial and other terms of the deal were not disclosed.